causal
Permission to leap drives breakthroughs
The recent concentration of biotech successes comes not just from expanded computational and biological capability but from reaching a critical mass of capital, confidence, and community that gives people 'permission to leap' beyond sequential incremental work—permission granted either by confidence or by need (e.g., a pandemic or a curable serious disease).
causalpending
Speaker
Noubar AfeyanEvidence Quote
“we've reached a level of capital, confidence, commitment, community... where people are willing to leap. They're not just incrementally doing "If A, then B, then B-prime, and then maybe C."”
Created: 6/12/2026, 4:54:48 PM
Your notes
Loading notes...